Browsing Tag

PRNewswire

54835 posts
BLUETTI Responds to Houston Storm: Seeking Relief Collaboration and Offering Tax Exemption for Texans

BLUETTI Responds to Houston Storm: Seeking Relief Collaboration and Offering Tax Exemption for Texans

LAS VEGAS, May 20, 2024 /PRNewswire/ — A severe thunderstorm swept through Texas…
Sanya Marks Sixth Anniversary of Establishing the Hainan FTP with Pledge to Boost Global Tourism Influence

Sanya Marks Sixth Anniversary of Establishing the Hainan FTP with Pledge to Boost Global Tourism Influence

SANYA, China, May 20, 2024 /PRNewswire/ — As Sanya marks the sixth…
IntouchCX Applauded by Frost & Sullivan for Enabling Seamless, Effortless, and Memorable Customer Interactions with Its Innovation-led Solutions Suite

IntouchCX Applauded by Frost & Sullivan for Enabling Seamless, Effortless, and Memorable Customer Interactions with Its Innovation-led Solutions Suite

IntouchCX’s targeted and effective innovation-led solutions suite helps clients improve productivity, customer…
Air Premia Launches New Service on San Francisco-Incheon Route, Operating Four Times Weekly

Air Premia Launches New Service on San Francisco-Incheon Route, Operating Four Times Weekly

–  This is Air Premia’s third route connecting the US mainland and…
Curated by teachers and students, exhibition of Asian Civilizations on Silk Roads opens at Zhejiang University

Curated by teachers and students, exhibition of Asian Civilizations on Silk Roads opens at Zhejiang University

HANGZHOU, China, May 20, 2024 /PRNewswire/ — The exhibition Communication and Innovation:…
BingX Marks Sixth Anniversary with Comprehensive Global Expansion Strategy

BingX Marks Sixth Anniversary with Comprehensive Global Expansion Strategy

Set to launch USDC-margined futures trading Introducing Launchpad and Launchpool for token…
Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA

Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA

First Allogeneic T-Cell Therapy BLA Submission to U.S. Food and Drug Administration …
Youlife International and Distoken Acquisition Corporation Announce Definitive Business Combination Agreement

Youlife International and Distoken Acquisition Corporation Announce Definitive Business Combination Agreement

Youlife International to Go Public in the U.S. Through such Business Combination,…